AUTOLUS THERAPEUTICS ($AUTL) posted quarterly earnings results for Q1 2026 on Thursday, May 14th. The company reported earnings of -$0.27 per share, missing estimates of -$0.26 by $0.01. The company also reported revenue of $26,220,000, missing estimates of $26,684,077 by $-464,077.
You can see Quiver Quantitative's $AUTL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AUTOLUS THERAPEUTICS Hedge Fund Activity
We have seen 39 institutional investors add shares of AUTOLUS THERAPEUTICS stock to their portfolio, and 47 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 4,884,452 shares (-80.8%) from their portfolio in Q4 2025, for an estimated $9,720,059
- MAK CAPITAL ONE LLC added 3,987,727 shares (+15.3%) to their portfolio in Q4 2025, for an estimated $7,935,576
- BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. added 3,361,156 shares (+inf%) to their portfolio in Q4 2025, for an estimated $6,688,700
- DEEP TRACK CAPITAL, LP removed 2,568,613 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,111,539
- BLACKROCK, INC. removed 2,205,093 shares (-59.8%) from their portfolio in Q1 2026, for an estimated $3,043,028
- ARMISTICE CAPITAL, LLC added 1,900,000 shares (+12.2%) to their portfolio in Q4 2025, for an estimated $3,781,000
- ACADIAN ASSET MANAGEMENT LLC removed 1,776,520 shares (-98.5%) from their portfolio in Q1 2026, for an estimated $2,451,597
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
AUTOLUS THERAPEUTICS Analyst Ratings
Wall Street analysts have issued reports on $AUTL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 01/12/2026
To track analyst ratings and price targets for AUTOLUS THERAPEUTICS, check out Quiver Quantitative's $AUTL forecast page.
AUTOLUS THERAPEUTICS Price Targets
Multiple analysts have issued price targets for $AUTL recently. We have seen 3 analysts offer price targets for $AUTL in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Gil Blum from Needham set a target price of $10.0 on 04/09/2026
- Salim Syed from Mizuho set a target price of $10.0 on 03/31/2026
- Emily Bodnar from HC Wainwright & Co. set a target price of $9.0 on 02/17/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
